Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,878 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo.
Hashimoto K, Morishige K, Sawada K, Ogata S, Tahara M, Shimizu S, Sakata M, Tasaka K, Kimura T. Hashimoto K, et al. Biochem Biophys Res Commun. 2007 Apr 27;356(1):72-7. doi: 10.1016/j.bbrc.2007.02.102. Epub 2007 Feb 28. Biochem Biophys Res Commun. 2007. PMID: 17343825
In our previous study, GGA was shown to inhibit ovarian cancer invasion by attenuating Rho activation [K. Hashimoto, K. Morishige, K. Sawada, M. Tahara, S. Shimizu, M. Sakata, K. Tasaka, Y. ...
In our previous study, GGA was shown to inhibit ovarian cancer invasion by attenuating Rho activation [K. Hashimoto, K. …
miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
Ohyagi-Hara C, Sawada K, Kamiura S, Tomita Y, Isobe A, Hashimoto K, Kinose Y, Mabuchi S, Hisamatsu T, Takahashi T, Kumasawa K, Nagata S, Morishige K, Lengyel E, Kurachi H, Kimura T. Ohyagi-Hara C, et al. Among authors: hashimoto k. Am J Pathol. 2013 May;182(5):1876-89. doi: 10.1016/j.ajpath.2013.01.039. Epub 2013 Mar 15. Am J Pathol. 2013. PMID: 23499550
Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary.
Sasano T, Mabuchi S, Kuroda H, Kawano M, Matsumoto Y, Takahashi R, Hisamatsu T, Sawada K, Hashimoto K, Isobe A, Testa JR, Kimura T. Sasano T, et al. Among authors: hashimoto k. Mol Cancer Res. 2015 Apr;13(4):795-806. doi: 10.1158/1541-7786.MCR-14-0314. Epub 2014 Dec 17. Mol Cancer Res. 2015. PMID: 25519148 Free PMC article.
IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment.
Kinose Y, Sawada K, Makino H, Ogura T, Mizuno T, Suzuki N, Fujikawa T, Morii E, Nakamura K, Sawada I, Toda A, Hashimoto K, Isobe A, Mabuchi S, Ohta T, Itai A, Morishige K, Kurachi H, Kimura T. Kinose Y, et al. Among authors: hashimoto k. Mol Cancer Ther. 2015 Apr;14(4):909-19. doi: 10.1158/1535-7163.MCT-14-0696. Epub 2015 Jan 30. Mol Cancer Ther. 2015. PMID: 25637316
7,878 results